In the TCGA dataset, a total of 408 NSCLC samples (230 adenocarcinomas and 178 squamous cell carcinomas) that had not been treated with chemotherapy, including EGFR-TKIs, were analyzed, and 30 samples had EGFR mutations in exons 18–21. Here, EGFR is linked to non-small cell lung carcinoma.